Bayer Aspirin

Brand Origin and Manufacturing

Bayer AG, founded in 1863 in Barmen, Germany, is renowned for its pharmaceutical products, notably Aspirin, introduced in 1899. Aspirin is produced in multiple countries, ensuring global availability.

Ownership Structure

Bayer AG remains an independent entity, with no subsidiaries owning the brand locally. The company is publicly traded, with significant shareholders including Temasek Holdings (3.5%), Norges Bank (3.1%), and Silchester International Investors (3.0%).

Recent Developments

In 2016, Bayer acquired Monsanto, a move that has faced challenges due to ongoing litigation concerning Monsanto's herbicide Roundup. Despite these challenges, Bayer continues to focus on its core divisions: Pharmaceuticals, Consumer Health, and Crop Science.

Conclusion

Bayer's commitment to quality and innovation has solidified its position as a leading pharmaceutical company, with Aspirin remaining a cornerstone of its product portfolio.